22nd Century Group (NASDAQ:XXII) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII) in a report issued on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock.

22nd Century Group Stock Performance

Shares of XXII stock opened at $0.10 on Tuesday. The company’s fifty day moving average price is $0.16 and its 200-day moving average price is $0.58. The stock has a market cap of $4.59 million, a PE ratio of 0.00 and a beta of 1.45. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. 22nd Century Group has a 12 month low of $0.08 and a 12 month high of $5.28.

22nd Century Group (NASDAQ:XXII) last posted its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) EPS for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group as of its most recent filing with the Securities & Exchange Commission. 18.06% of the stock is owned by hedge funds and other institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.